Abstract
DOI of original article: 10.1016/j.addr.2007.08.042. ☆ This review is part of the Advanced Drug Delivery Reviews theme issue on “Lipid-based systems for the enhanced delivery of poorly water soluble drugs”. ⁎ Corresponding author. Canadian Institutes of Health Research Chair in Pharmaceutical Drug Development, Canada. Tel.: +1 604 822 4889; fax: +1 604 822 3035. E-mail address: kwasan@interchange.ubc.ca (K.M. Wasan). Table 1 Plasma creatinine and amphotericin B (AmpB) concentrations after administration of a single intravenous dose of deoxycholate (DOC)–AmpB and a single oral gavage of DOC–AmpB and various AmpB lipid formulations to male Sprague–Dawley rats (350–400 g)
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
